pembrolizumab fda label 2022

Keyword Analysis

Keyword	CPC	PCC	Volume	Score	Length of keyword
pembrolizumab fda label 2022	0.2	0.1	713	10	28
pembrolizumab	0.22	0.2	9328	93	13
fda	0.64	0.1	6469	37	3
label	0.97	0.3	7528	78	5
2022	0.85	0.7	2918	35	4

Keyword	CPC	PCC	Volume	Score
pembrolizumab fda label 2022	1.85	1	731	43
pembrolizumab fda label 2023	1.24	1	2000	16
pembrolizumab fda label 2021	0.62	1	3776	13
pembrolizumab fda approval history	0.48	0.6	2368	92
pembrolizumab fda approved indications	0.61	0.5	1860	23
when was pembrolizumab fda approved	1.33	0.3	7362	10
pembrolizumab package insert 2022	1.76	0.4	1625	100
pembrolizumab package insert fda	0.82	0.3	4683	55
fda approval pembrolizumab breast cancer	0.76	0.5	8544	92
pembrolizumab fda approval melanoma	1.92	0.9	2615	50
pembrolizumab fachinformation 2022 pdf	1.82	0.9	6541	95
pembrolizumab j code 2022	1.07	0.2	9955	49
pembrolizumab lung cancer fda approval	0.66	0.1	8350	86
pembrolizumab lung cancer fda	1.42	0.8	9016	36
pembrolizumab fda approval nsclc	0.6	0.3	8480	94
pembrolizumab fda approval endometrial cancer	1.1	0.5	8698	82
pembrolizumab gastric cancer fda approval	0.23	0.3	8084	19
pembrolizumab product monograph canada	0.85	0.4	6108	21
pembrolizumab patient information leaflet	0.02	0.4	3026	80
high tmb pembrolizumab fda	0.02	0.2	6989	8
when was pembrolizumab approved	0.06	0.3	7574	99
pembrolizumab patent expiry date	0.8	0.3	4652	40
pembrolizumab breast cancer approval	0.17	0.7	10	75